|
⚲
|
| Keyboard |
| OH Andrew M
✚
|
|
|---|---|
| CIK # | 0001746614 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001746614] | |
| 4 | [0001746614] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Syros Pharmaceuticals Inc | |
| OH Andrew M | |
| Rubius Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-06-05 | Grant | 4,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2024-06-05 | Grant | 6,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2023-06-01 | Grant | 6,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2023-06-01 | Grant | 4,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2022-09-16 | Grant | 8,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Stock Option (right to buy) · derivative
|
2022-09-16 | Grant | 12,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Common Stock
|
2020-05-15 | Option exercise | 5,000 | $4.74 | 23,700 |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2020-05-15 | Option exercise | 5,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2020-01-31 | Grant | 165,000 | $0.00 | |
|
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
|
2019-01-31 | Grant | 115,000 | $0.00 |